Largemouth Bass Virus (LMBV): Virology, Pathogenesis, and Control

Introduction and Taxonomic Classification

Largemouth Bass Virus (LMBV) is a highly pathogenic aquatic virus that causes significant mortality in farmed largemouth bass (Micropterus salmoides) [1]. LMBV belongs to the genus Ranavirus within the family Iridoviridae [2, 3]. Ranaviruses are promiscuous pathogens capable of infecting many lower vertebrates, including fish, amphibians, and reptiles [3]. Within the context of aquatic virology, LMBV is one of several iridoviruses affecting perciform fish, along with other agents such as Red Sea Bream Iridovirus and Grouper Iridovirus. The economic impact of LMBV on the largemouth bass aquaculture industry is substantial, as outbreaks can result in cumulative mortality rates exceeding 50% in affected populations [1]. No licensed therapies are currently available for LMBV, which has driven research into antiviral compounds and vaccine candidates [4].

Virion Structure and Genome Organization

Mature LMBV virions are icosahedral particles approximately 150 nm in diameter, as determined by transmission electron microscopy [2]. The viral capsid exhibits a hexagonal profile in thin section, consistent with the typical morphology of iridoviruses [2]. The virus particle contains a double-stranded DNA genome that is enclosed within an inner lipid membrane and an outer protein capsid [3].

Complete genome sequencing of LMBV isolates, including the strain designated MSRaV (Micropterus salmoides ranavirus), has revealed genome lengths of approximately 99,171 base pairs [3]. The genome encodes 105 predicted open reading frames (ORFs) [3]. Among these, the major capsid protein (MCP) gene is highly conserved and is a primary target for molecular detection assays [5]. Sequence analysis of the MCP gene from LMBV isolates associated with ulcerative syndrome has enabled the development of rapid PCR-based diagnostic methods [5]. Comparative genomic analyses show that LMBV shares high sequence identity with other ranaviruses from perciform hosts, and phylogenetic clustering places LMBV within a distinct clade of fish ranaviruses [3]. Eleven predicted proteins exhibit differences between LMBV and related ranavirus isolates, with only one protein (79L) showing a relatively large divergence [3]. Notably, 12 proteins encoded by LMBV have no recognizable homologs in iridoviruses from non-piscine hosts, suggesting a degree of host-adaptive evolution [3].

Viral Replication Cycle and Morphogenesis

The morphogenesis of LMBV has been elucidated using epithelioma papulosum cyprinid (EPC) cells infected at a multiplicity of infection of 0.1 [2]. The replication cycle progresses through well-defined stages. Virus entry occurs via endocytosis or direct penetration of the cell membrane [2]. After internalization, virions are observed within cytoplasmic vesicles or lysosomes [2]. Following capsid uncoating, the viral genome traverses the nuclear membrane and enters the cell nucleus, where genome replication takes place [2]. Progeny genomes are then transported to the cytoplasm for assembly within electron-dense areas termed viromatrices [2]. Within the viromatrix, assembling capsids aggregate into pseudocrystalline arrays [2]. Mature virions are released by budding from the host cell plasma membrane [2]. The complete replication cycle, from entry to release, is typically completed within 72 to 96 hours post-infection [2].

Host Range and Clinical Disease

LMBV infects primarily largemouth bass, but the virus has been isolated from other perciform species, including mandarin fish (Siniperca chuatsi) [3]. The virus induces cytopathic effects (CPE) in cell lines derived from both fish and amphibians, indicating a relatively broad in vitro host range [3]. In vivo, the disease manifests as an acute viral infection with clinical signs including lethargy, erratic swimming, and hemorrhagic lesions on the skin and fins [1]. Ulcerative syndrome, characterized by dermal erosions and necrotic foci, has been attributed to LMBV infection in some outbreaks [5]. Mortality typically peaks 7 to 14 days after exposure, and survivors may remain subclinically infected [1]. LMBV is considered one of the major viral pathogens alongside Micropterus salmoides rhabdovirus (MSRV) and bacterial agents such as Nocardia spp. and Aeromonas spp. in intensive aquaculture systems [1].

Pathogenesis and Host Immune Responses

LMBV pathogenesis involves the induction of apoptosis in infected host cells, a process mediated at least in part by the PI3K and ERK signaling pathways [6]. Inhibition of these pathways reduces viral replication and apoptosis, suggesting that LMBV exploits host cell survival and death signaling to facilitate its propagation [6]. In infected fish, the virus establishes systemic infection with high viral loads in the liver, spleen, and kidney [4]. Histopathological examination reveals necrosis and inflammation in these target organs [4]. Host immune responses include the upregulation of antiviral interferons (IFN-alpha and IFN-gamma) and interferon-stimulated genes such as Mx1, ISG15, and Viperin [7]. However, LMBV can modulate the immune response by inducing excessive production of reactive oxygen species (ROS) and pro-inflammatory cytokines, leading to immunopathology [4]. Studies using primary gill cell cultures derived from largemouth bass demonstrate that these cells are highly susceptible to LMBV infection and mount a robust antiviral transcriptional response [7]. The establishment of such primary cell culture systems provides a valuable in vitro platform for studying host-virus interactions without the confounding factors of immortalized cell lines [7].

Diagnostic Methods

Rapid and accurate diagnosis of LMBV is essential for disease management. PCR amplification of the MCP gene is a widely used molecular detection method [5]. The assay can detect viral DNA from tissue homogenates of liver, spleen, and kidney, and from cell culture supernatants [5]. Virus isolation on susceptible cell lines such as EPC or primary fish cells remains a gold standard for confirmation [7, 2]. Transmission electron microscopy can be employed to visualize characteristic icosahedral virions approximately 150 nm in diameter [2]. Quantitative real-time PCR (qRT-PCR) targeting viral genes allows viral load quantification and monitoring of disease progression [4]. Serological methods, such as enzyme-linked immunosorbent assays, are less commonly used but may aid in seroprevalence studies. The following diagnostic decision flowchart summarizes the typical workflow.

graph TD
 A[Clinical suspicion: lethargy, ulcers, mortality] --> B[Necropsy: collect liver, spleen, kidney]
 B --> C{Diagnostic approach}
 C --> D[PCR: MCP gene detection]
 C --> E[Virus isolation: EPC or primary gill cells]
 D --> F[Positive: CPE confirmation if needed]
 E --> G[CPE observed: TEM for virion morphology]
 F --> H[Definitive diagnosis: LMBV positive]
 G --> H
 H --> I[Quantify viral load: qRT-PCR]
 I --> J[Implement control measures: biosecurity, consider antivirals]

Antiviral Strategies and Vaccine Development

Owing to the lack of licensed vaccines or drugs for LMBV, research has focused on repurposing natural compounds and developing experimental vaccines. Aloe-emodin (AE), a natural anthraquinone, exhibits potent anti-LMBV activity in vitro and in vivo [4]. In cell culture, AE at 10 mg/L suppressed viral replication by 91.8%, reducing viral titers from 10^5.92 to 10^4.17 TCID50/0.1 mL at 96 hours post-infection [4]. AE alleviated cytopathic effects, maintained cytoskeletal integrity, and reduced the overproduction of reactive oxygen species [4]. In vivo, intraperitoneal injection of AE at 0.5 mg/kg increased survival from 19% to 49% and reduced viral titers in the liver, spleen, and kidney [4]. Horizontal transmission experiments showed that AE suppressed viral shedding by 95% from donor fish and reduced transmission efficiency by up to 66% in dual donor-recipient treatments [4]. Mechanistically, AE upregulated antiviral interferons (IFN-alpha/gamma) and downregulated pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha) at the mRNA level [4].

For vaccine development, live-attenuated and inactivated formulations have been explored, primarily for the related rhabdovirus MSRV, but the approaches are conceptually applicable to LMBV [8]. Lyophilized formulations incorporating thermostable protectants have been developed to improve shelf life and immunogenicity [8]. Table 1 summarizes key antiviral compounds and vaccine approaches relevant to LMBV and related largemouth bass viruses.

Table 1. Experimental antivirals and vaccine approaches for LMBV and related viruses in largemouth bass.

Note: Milbemycin A4 [9], EGCG [10], and the freeze-dried MSRV vaccine [8] were tested against Micropterus salmoides rhabdovirus (MSRV), a different virus from LMBV. Their inclusion here illustrates the range of investigational strategies applicable to aquatic viral diseases in largemouth bass.

The PI3K and ERK signaling pathways have also been identified as potential therapeutic targets, as inhibition of these pathways reduces LMBV replication and apoptosis [6].

Frequently Asked Questions

What is the host range of Largemouth Bass Virus?

LMBV primarily infects largemouth bass (Micropterus salmoides) but has also been isolated from mandarin fish and can replicate in cell lines from both fish and amphibians [3].

How is LMBV transmitted between fish?

Horizontal transmission is the primary route; infected fish shed virus into the water, and naive fish become infected via the gills or skin [4]. Aloe-emodin treatment significantly reduces shedding and transmission efficiency [4].

What are the key clinical signs of LMBV infection?

Infected fish present with lethargy, erratic swimming, hemorrhagic skin lesions, and ulcerative syndrome, often leading to acute mortality within 7-14 days [1, 5].

Which diagnostic test is most commonly used for LMBV?

PCR targeting the major capsid protein (MCP) gene is the most rapid and sensitive molecular diagnostic method [5]. Virus isolation on EPC or primary gill cells followed by electron microscopy provides confirmatory morphological data [7, 2].

Is there an effective antiviral treatment for LMBV in aquaculture?

No commercial antiviral is approved. Aloe-emodin has shown strong experimental efficacy in reducing viral replication and transmission, but it is not yet licensed for aquaculture use [4]. Research into other compounds is ongoing [9, 10].

Can LMBV be prevented by vaccination?

No licensed vaccine currently exists for LMBV. Experimental live-attenuated and inactivated vaccines have been developed for the related MSRV, providing proof of concept for LMBV vaccine development [8].

References

[1] Yang S, Zhao J, An N, et al. Updates on infectious diseases of largemouth bass: a major review. Fish and Shellfish Immunology. 2024. URL: https://www.semanticscholar.org/paper/7414c90f781ccd6bfee774b87a8cbe584ad88ad4

[2] Zhang M, Yang T, Li Y, et al. Morphogenesis of largemouth bass ranavirus (LMBRaV) in the epithelioma papulosum cyprinid cell line. Israeli Journal of Aquaculture (Bamidgeh). 2024. URL: https://www.semanticscholar.org/paper/b42768bfd240762114c166928029ac06ab93d411

[3] Yu X, Ke F, Zhang QY, et al. Genome characteristics of two ranavirus isolates from mandarin fish and largemouth bass. Pathogens. 2023. URL: https://www.semanticscholar.org/paper/735a4b009390d191ee6825cb2a1b058e61efc135

[4] Zhang Z, Yang B, Wang M, et al. Aloe-emodin provides dual protection against largemouth bass virus via antiviral activity and host immune enhancement. Fish and Shellfish Immunology. 2025. URL: https://www.semanticscholar.org/paper/2c127768c90691e2193e2ed8fde40079cc931d5c

[5] Xiaoyan J. Sequence analysis of MCP gene from largemouth bass ulcerative syndrome virus and rapid detection by PCR assay. 2010. URL: https://www.semanticscholar.org/paper/4c945d29236b86485a8966ca20ddd041b4cad6e5

[6] Huang X, Wang W, Huang Y, et al. Involvement of the PI3K and ERK signaling pathways in largemouth bass virus-induced apoptosis and viral replication. Fish Shellfish Immunol. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/25260912/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[7] Wang Z, Nie L, Fei C, et al. Establishment of gill-derived primary cell cultures from largemouth bass (Micropterus salmoides) as an alternative platform for studying host-virus interactions. Fishes. 2025. URL: https://www.semanticscholar.org/paper/046ab580ad602b6d25d02d6b8a69612a1866de3c

[8] Liang H, Hu G, Luo X, et al. Preparation and efficacy evaluation of heat-resistant freeze-dried live-attenuated vaccine formulation of Micropterus salmoides rhabdovirus. Vaccines. 2026. URL: https://www.semanticscholar.org/paper/d53f24093bfbdd22bab41cde8bcecb933c9d49d7

[9] Shao Q, Zhou Y, Tong X, et al. Milbemycin A4, derived from Streptomyces bingchenggensis exhibits antiviral activity against MSRV in vitro and in vivo. Journal of Fish Diseases. 2026. URL: https://www.semanticscholar.org/paper/af0d853054c3ce7691efcb38703e4541025788f2

[10] Wang Y, Mao S, Feng X, et al. Epigallocatechin gallate (EGCG) inhibits Micropterus salmoides rhabdovirus replication via suppressing viral attachment and infectivity. Fish and Shellfish Immunology. 2025. URL: https://www.semanticscholar.org/paper/74b109774cd0c8b322f9ba837c39c92620ec4f10